ROBERTA ESCALERA: Open Payments
NPI 1225672785 · MESA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,391 in 72 payments from 29 companies in 2025. Trend: 2023 $865 · 2024 $2,071 · 2025 $1,391
Food & beverage: $1,391
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 11 | $169 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $108 |
| Lundbeck LLC | 5 | $87 |
| Teva Pharmaceuticals USA, Inc. | 3 | $87 |
| Mannkind Corporation | 5 | $83 |
| Insulet Corporation | 4 | $82 |
| Aimmune Therapeutics, Inc. | 3 | $78 |
| Abbott Laboratories | 3 | $62 |
| Optinose US, Inc. | 3 | $60 |
| Ascendis Pharma Endocrinology Inc | 2 | $53 |
Products named: REXULTI, CAPLYTA, AUSTEDO XR, AFREZZA, Omnipod, ZENPEP, FREESTYLE LIBRE 3, Xhance.
Industry payments across AZ — which companies pay providers there.
